About the Authors
- Héla Saïdi
-
Contributed equally to this work with: Héla Saïdi, Marlène Bras
Affiliation Institut Pasteur, Antiviral Immunity, Biotherapy and Vaccine Unit, Infection and Epidemiology Department, Paris, France
- Marlène Bras
-
Contributed equally to this work with: Héla Saïdi, Marlène Bras
Affiliation Institut Pasteur, Antiviral Immunity, Biotherapy and Vaccine Unit, Infection and Epidemiology Department, Paris, France
- Pauline Formaglio
-
Affiliation Institut Pasteur, Antiviral Immunity, Biotherapy and Vaccine Unit, Infection and Epidemiology Department, Paris, France
- Marie-Thérèse Melki
-
Affiliation Institut Pasteur, Antiviral Immunity, Biotherapy and Vaccine Unit, Infection and Epidemiology Department, Paris, France
- Bruno Charbit
-
Affiliation Institut Pasteur, Antiviral Immunity, Biotherapy and Vaccine Unit, Infection and Epidemiology Department, Paris, France
- Jean-Philippe Herbeuval
-
Affiliation Chemistry and biology, nucleoside and immunology for therapy CBNIT, CNRS, UMR8601, Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, Université Paris Descartes, PRES Sorbonne Paris Cité, CICB Paris, Paris, France
- Marie-Lise Gougeon
-
* E-mail: mlgougeo@pasteur.fr
Affiliation Institut Pasteur, Antiviral Immunity, Biotherapy and Vaccine Unit, Infection and Epidemiology Department, Paris, France
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: HS MB MLG. Performed the experiments: HS MB PF MTM BC JPH. Analyzed the data: HS MB PF MTM BC JPH MLG. Wrote the paper: HS MB JPH MLG.